Sub-minimum inhibitory concentration ceftazidime inhibits Escherichia coli biofilm formation by influencing the levels of the ibpA gene and extracellular indole. (2nd January 2020)

• Record Type: Journal Article
• Authors: Sun, Fengjun; Yuan, Qian; Wang, Yu; Cheng, Lin; Li, Xiaoyu; Feng, Wei; Xia, Peiyuan
• Is Part Of: Journal of chemotherapy. Volume 32:Number 1(2020)
• Page Start: 7
• Page End: 14
• Publication Date: 2020-01-02
• Subjects: Sub-minimum inhibitory concentration -- Ceftazidime -- Escherichia coli -- Biofilm -- Indole -- ibpA; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; 615.58
• DOI: 10.1080/1120009X.2019.1678913
• Languages: English
• ISSNs: 1120-009X

Abstract

Abstract : Escherichia coli is a common pathogen of bacterial biofilm infections. Sub-minimum inhibitory concentration ceftazidime (sub-MIC CAZ) could inhibit the biofilm formation of E. coli . Deletion of the ibpAB genes could increase the extracellular indole concentration of E. coli and then inhibit biofilm formation. Therefore, we speculated that sub-MIC CAZ might inhibit biofilm formation via ibpAB . In this study, the results showed that sub-MIC CAZ could significantly inhibit biofilm formation, swimming motility and the expression of the ibpA gene, while it could increase the expression of tnaA gene and extracellular indole concentration. Knockout of the ibpA gene resulted in a decrease in biofilm formation and swimming motility and an increase in the indole concentration. When treated with sub-MIC CAZ, the tnaA gene expression, indole concentration, biofilm formation and swimming motility of MG1655 Δ ibpA were similar to those of the control group. The results indicated that sub-MIC CAZ might inhibit the biofilm formation of E. coli by increasing the extracellular indole concentration and downregulating the ibpA gene.